Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Liberum upgrades Smith & Nephew to 'buy'
(Sharecast News) - Liberum upgraded Smith & Nephew on Wednesday to 'buy' from 'hold' and hiked the price target to 1,410p from 1,120p, saying it would look to buy on dips given the recent run.
"While some may say they can hear the sound of a stable door closing in the distance, we don't think the horse has got that far yet and we are turning buyers on SN," the broker said.
It said it was a holder of the stock previously on the basis that it feared it would take longer than expected for the company to turn around the orthopaedics division and that the targets in the market didn't reflect that risk.
Liberum said S&N has largely addressed its concerns.
"To be clear we don't think that SN is out of the woods yet - we remain of the view that the turnaround in orthopaedics will take time and there is clearly plenty of execution risk around delivering the margin improvements - but we feel that SN has now set a much more realistic set of targets and given a lot more granular detail on how it will achieve those targets, which has given us a lot more confidence in its ability to deliver."
It added: "Yes, there is still execution risk, but with the shares still trading on low EBITDA multiples this is more than priced in."
I'm completely out now. I was underwhelmed with the results like many on here and was surprised to see the rise...having fallen back today I decided to take a very small profit and sit this out. In truth a dog of a share....Will keep watching potentially for lower entry or until such time the CEO actually puts his money where his mouth is
That's more like it
Uncle
When you say on the bases of this results may I ask you have you actually read all of the report line by line and digested the numbers too? I am not sure even the expert analyst done that yet.
There are loads of positive plans and outlooks embedded in to this result and numbers actually looking very promising. No wonder this is looking so strong today.
IMHO
£18 sometime, patience just required. Invest a core and trade the average price lower while collecting dividends. I see £20 £30 in the future.
remember AZN - who forsaw £100 per share when the share was £16
DGE who saw £35 when the share was £6-£8
UNVR who saw £42 when the shares price was £12
Uncle
Thanks for the post
If you go to further details if results and 12 points plans this is far better than analyst expected.
Yes I actually think £18 will achieve this year as the sale will ramp up on Q2 of this year
I think about the potentials and I know SN. would have a huge market on right climate
The bscklog you mentioned is not yet fully dealt with lots of delays clearing covid mess and admin related delays still goes on and patients are not yet flowing through the queue yet (globally and not just UK)
I still think SN. market opportunities is huge and big rise is in the pipeline
I personally going nowhere
But respect others decisions of what they like to do with their money.
This is stable and strong
Look at the chart and tell me what you see? I see a break out to above 1400 in no time. Remember my time scale is not days more or months
GLA
IMHO
DYOR
Surprised to see a 4% rise on this update. Results hardly knocking the lights out. Do you still reckon £18 by end of year Stockready1? On the basis of these results I very much doubt it. Q4 results poor when compared to last year's Q4 when Omicron was rife. This year should have seen a massive Covid backlog dealt with and revenue pouring in but it seems that hasn't happened.
Scarfell
Under current challenging climate and inflation and uncertainty to me this is a great results and soon this will be reflected on share price.
Once analyst read all of these this will be re-rated upwards... I am sure.
Shorter term I really don't care which direction this goes i am looking at 6 months and beyond not today or next months. That is where the real value is with this.
Again in my honest opinion
Please always do your own research
Good luck all
Analysts are digesting the news/results and to me this will be re-rated upwards soon.
Target will shift to 1600 and above IMHO
Look at the bigger picture and not what is happening right now. Today market is hot on the news and don't read too much to it /or act in rush, digest and reflect and be calm if you are a long termer stick with it (IMHO)
Jumping ship always costs me money but this is a steady ship and a strong one too
Again all IMHO
DYOR
GLA
Was expecting better results from the share price reaction this morning. Work is still in progress and no reason to sell but am not reaching for the buy button on these figures.
Might drop a bit tomorrow and go up again.... I meant
Small typo, sorry
From both technical and fundamentals this is the exact time to add or to hold.
I very much like the chart and trends that are forming here. To me is amazing
Might drop a big tomorrow the go up again but overal trends is clearly upwards.
Scanned the results very nicely put together and with covid behind us (mostly under control lets say) this is the year for SN.
I will hold for another year or so because that is where the real value comes. I am expecting upper 1400 in no time and then steady rise from there.
This is looking great and could see it coming
Enjoy whatever you decide to do
DYOR
IMHO
GLA
nothing to shot about - jam tomorrow - plan was to add on a dip or reduce on a spike whichever came first so pocketed 3k on the trade in my ISA and dropped my average by 50p per share. Let's see where it goes for the rest of the day as this is a great trade on days like today.
I read the results as generally inline and thought the market may take opp to mark this down but pleasantly surprised to see this up 5% on open.
I'm finally in profit on what has been an absolute dog of a share for the last year.
I had considered selling but I think the tide is turning and it's our turn to ride the wave up. GL to all those that have held on!
Somebody thinks its worth getting in now as double the usual volume today with over 4m shares traded
Anyone shed any light on the 2 x 1M off book trades this evening
Hopefully the big Institutions are realising the potential here and I may just get lucky by holding on and keeping the faith :o)
Been on a good steady run since October up 23%. Thinking of adding, but not yet. Going to wait and see what the results look like.
Always only a bid away from making a fortune here :)
So we will have year end results on 21 February. That’s see if our CEO has earned his corn before issuing further free shares.
I agree Deadly4U, in hindsight I would of purchased in the lows of October, but I missed that opportunity, have I come in at the perfect entry point, most definitely not (I believe I missed that boat). I haven't come in too heavy as I did with RR, so if the share price goes down, I wont be losing any sleep, I just thought it would be a good addition for myself, and I hope the sales figures head north, share price rises and dividends rise too, and we all do well. Heres hoping
sp has moved up nicely in the last couple of months, but if earnings dont show any improvement we will be dumped back to September lows
Added SN. to my portfolio the other day, my heart said to load up more on Rolls Royce, but my brain tells me to to get my portfolio more diversified a I am buying as a LTH, certainly wont be adding any more aim stocks to my portfolio, no,no,no, Ill leave that to the gamblers and the best of luck to them too.
So here's hoping for a a steady recovery throughout the next few years, and I hope I have chosen wisely.
GLA.
certainly not selling, adding and trimming and increasing holding.
This is the exact time people should hold this and add more
My prediction for this is £18 at some point this year or towards end of this year.
Massive upside here on various basis technical and upcoming data.
I love SN. and I believe is one of the bargains around which not many people not yet realised
Stay put or add
IMHO
DYOR
certainly a recovery stock, about time it was rerated.
I am still waiting for the ones I bought in 2017 to regain their original price.